January 8, 2024 by Chain Drug Review
Brad Cochran, Claire Biermass, Jeff Leger, Jennifer Zilka, Prem Shah, Retail Forecast 2024, Scott Miller, Todd Gustin, Tracey Brown
Business, January 8, 2024, Leading Headlines, Retail News
Leading chain drug and distribution executives provide their outlook for the coming year on the following pages, spelling out the challenges and opportunities that lie ahead for their companies and the industry. Prem Shah Executive Vice President, Chief Pharmacy Officer and President, Pharmacy and Consumer Wellness, CVS Health The need for accessible and affordable care
January 10, 2022 by Chain Drug Review
Andy Becker, Brent Stutz, Calvin LeRoux, Carmen Churcott, Chris Chiew, Debbie Weitzman, Eyad Farah, George Rafferty, Grady Brown, Jennifer Zilka, Joe Douglas, John Standley, Michelle Peluso, Prem Shah
January 10, 2022, Leading Headlines, Retail News
With the pandemic surging, pharmacy chains are planning for new solutions to fight the variants. At the same time retailers are looking to broaden affordable and accessible health care offerings when many people find such services from more traditional providers out of financial reach. Chains are also bolstering their e-commerce appeal to entice omnichannel shoppers.
December 6, 2021 by Chain Drug Review
CVS Health, National Influenza Vaccination Week, Prem Shah
Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health marks National Influenza Vaccination Week (NIVW) (December 5-11) by reminding everyone that it’s not too late to get a flu shot. As the country continues the fight against the COVID-19 pandemic, a flu shot remains the most effective way to protect against seasonal flu and is an important step individuals
April 20, 2020 by Chain Drug Review
COVID-19, CVS Health, Dr. Sree Chaguturu, Prem Shah, UCLA Health
Leading Headlines, Pharmacy
WOONSOCKET, R.I. — CVS Health is working with hospitals and providers, including UCLA Health, to support solutions for creating much-needed hospital bed capacity during the pandemic. Coram has enhanced its existing home infusion capacity and capabilities to help transition eligible IV-therapy patients to home-based care. This includes enhanced clinical monitoring, virtual support and oversight through